La Trobe

Inflammasome Activation Mediates Apoptotic and Pyroptotic Death in Astrocytes Under Ischemic Conditions

Download (1.14 MB)
journal contribution
posted on 2024-01-19, 01:25 authored by LJ Wong, BWL Lee, YJ Sng, L Poh, Vismitha RajeevVismitha Rajeev, S Selvaraji, Grant DrummondGrant Drummond, Christopher SobeyChristopher Sobey, Thiruma ArumugamThiruma Arumugam, DY Fann
Inflammation is a hallmark mechanism of ischemic stroke-induced brain injury. Recent studies have shown that an intracellular multimeric protein complex known as an inflammasome is a key factor for inducing an inflammatory response, and apoptotic and pyroptotic cell death in ischemic stroke. Inflammasome assembly leads to the activation of pro-inflammatory caspases, and the maturation and secretion of pro-inflammatory cytokines IL-1β and IL-18. While the role of inflammasomes in ischemic stroke-induced neuronal death, and microglial activation and cell death have been established, little is known about the role of inflammasomes in astrocytes under ischemic conditions. In this study, we investigated the expression and activation of inflammasome components in protoplasmic and fibrous astrocytes under ischemic conditions. We found that both protoplasmic and fibrous astrocytes expressed a differential increase in inflammasome protein components, and that their activation promoted maturation of IL-1β and IL-18, and secretion of IL-1β, as well as initiating apoptotic and pyroptotic cell death. Pharmacological inhibition of caspase-1 decreased expression of cleaved caspase-1 and production of mature IL-1β, and protected against inflammasome-mediated apoptotic and pyroptotic cell death. Overall, this study provides novel insights into the role of inflammasome signaling in astrocytes under ischemic conditions.

Funding

This work was supported by the National Medical Research Council Research Grants (NMRC-CBRG-0102/2016 and NMRC/OFIRG/0036/2017) in Singapore and the National Health and Medical Research Council of Australia (Grant Identification Number 2019100).

History

Publication Date

2023-12-01

Journal

NeuroMolecular Medicine

Volume

25

Issue

4

Pagination

12p. (p. 533-544)

Publisher

Springer Nature

ISSN

1535-1084

Rights Statement

© 2023 The Authors. This version of the article has been accepted for publication in NeuroMolecular Medicine, after peer review and is subject to Springer Nature’s AM terms of use (see https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms), but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s12017-023-08753-2